Showing results (41-50 of 253) with videos related to
Sort By:
Pageof 26
Transfusion|March 30, 2010
Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testingShimian Zou, Kerri A Dorsey, Edward P Notari, et al.Archives of Pathology & Laboratory Medicine|May 10, 2007
Current risks of transfusion-transmitted agents: a reviewSusan L StramerTransfusion|October 6, 2025
Prevalence of HIV, HBV, and HCV in United States blood donations, 2015-2023: The transfusion-transmissible infections monitoring system (TTIMS)Emilya Huseynova, James Haynes, Edward P Notari, et al.Transfusion|May 19, 2025
Urban versus rural blood donors in the United States and the relationship with transfusion-transmissible infectionsGalen Conti, Edward P Notari, Roger Y Dodd, et al.Transfusion|December 5, 2014
Risk factors for retrovirus and hepatitis virus infections in accepted blood donorsBrian Custer, Debra Kessler, Farnaz Vahidnia, et al.The New England Journal of Medicine|August 20, 2004
Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testingSusan L Stramer, Simone A Glynn, Steven H Kleinman, et al.Transfusion|December 28, 2018
Impact of one-time testing for Trypanosoma cruzi antibodies among blood donors in the United StatesRoger Y Dodd, Jamel A Groves, Rebecca L Townsend, et al.Transfusion|June 6, 2026
First-time blood donor demographics and characteristics during the individual donor assessment versus 3-month deferral policies for high-risk behaviorsGalen Conti, Emilya Huseynova, Susan L Stramer, et al.Transfusion|April 25, 2024
Changes in transfusion-transmissible infection prevalence and demographics among US blood donors during the COVID-19 pandemicGalen Conti, Edward P Notari, Roger Y Dodd, et al.International Journal of Hematology|December 24, 2004
Current safety of the blood supply in the United StatesRoger Y DoddPageof 26